Medexus Pharmaceuticalsincis An Innovative Specialty Pharmaceutical Company Focused On North Americaformed In September 2018 Through The Merger Of Three Companiesmedexus Has Established A Scalable Business Model That Encompasses Commercial Operationssupply Chain Managementregulatory Affairsand Medical Affairsthe Company Operates Through Two Segmentsmedexus Pharma Canada And Medexus Pharma Usadelivering Specialty And Rare Disease Products Across The Region Medexus Offers A Diverse Range Of Products Targeting Various Therapeutic Areasthis Includes Rupall For Allergiesixinity For Hemophilia Band Trecondyv For Oncology Treatmentsthe Company Also Provides Unique Formulations Of Methotrexatesuch As Rasuvo And Metojectfor Rheumatology And Autoimmune Diseasesadditionallymedexus Has Developed Gleolanan Optical Imaging Agent For Glioma Surgeriesthe Company Aims To Enhance Quality Of Life Through Its Innovative Prescription And Over The Counter Brands While Fostering A Collaborative Work Environment For Its Employees
No conferences found for this company.
| Company Name | Medexus Pharmaceuticals Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
